If they get to use Yosts patent they should not get their incentive shares. I thought the incentive shares are for approval of their original patent they applied for. This original patent would then be negligible as they are using Yosts
Medchem, you are a lot more savy about the science than most. I was wondering if you can explain to us the magic behind the model that the Colorado police are working with that detects several different vices. Shell might be able to help in that regard too. The existence of a trial model gives me more hope than ever that the scientific community accepts this as a possibility or my guess is they wouldn't be wasting their time. Minaturization seems to be the issue. I remember in BC when they first launched the alcohol breathalyzer they used to pack it to roadblocks in a cube van called the BATMOBILE. I think it was the big model that they still confirm the roadtest with at the police station. I don't know if it was the cost or availability or just the fact that they hadn't made it small enough for every police car. They obviously felt the need for the alcohol breathalyzer so given the changing attitude of society towards pot i'm guessing we are in the same boat now. Nobody wants to deal with swabs and body fluids except trained medical professionals and the beauty of the THC breathalyzer if it only detects for the last few hours we won't lose half our labour force. That is just as serious an issue as driving under the influence plus the body fluid thing is putting your DNA on record and that is too much information imo. glta and dyodd
Market Data 
Markets 
AI
